Subscribe to our newsletter
V-Bio News
Biodol Therapeutics receives €4.5 million to progress its novel pain medication in a Series A led by V-Bio Ventures
Published on: August-31, 2020
V-Bio Ventures invests in RootWave in a EUR 6.5 m Series A financing to develop and market electrical weed killing solutions
Published on: December-16, 2019
V-Bio Ventures invests in Augustine Therapeutics, a VIB and KU Leuven spin-off to fight neuromuscular diseases
Published on: December-16, 2019
V-Bio Ventures leads AgomAb Therapeutics’ Euros 21m Series A Financing
Published on: April-3, 2019
Portfolio News
Camel-IDS appoints Ruggero Della Bitta MD, PhD, as Chief Medical Officer
Published on: Okt-8, 2019
Camel-IDS appoints Thomas Ramdahl as Independent Director
Published on: May-17, 2019
Syndesi Therapeutics announces initiation of Phase I study of novel SV2A modulator
Published on: May-8, 2019
Confo Therapeutics raises €30 million in Series A financing
Published on: May-7, 2019
Newsletter
V-Bio Ventures Newsletter March 2020
Published on: March 5, 2020
V-Bio Ventures Newsletter October 2019
Published on: October 3, 2019
V-Bio Ventures Newsletter June 2019
Published on: June 6, 2019
V-Bio Ventures Newsletter February 2019
Published on: Februari 8, 2019
V-Bio Ventures Newsletter October 2018
Published on: October 3, 2018
V-Bio Ventures Newsletter june 2018
Published on: June 8, 2018